Study of Romiplostim for Chemotherapy Induced Thrombocytopenia

NCT02052882 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Isolated Chemotherapy-induced Thrombocytopenia

Interventions

BIOLOGICAL: romiplostim

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]